Hepatitis B virus transactivator MHBst: activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization

EMBO J. 1992 Aug;11(8):2991-3001. doi: 10.1002/j.1460-2075.1992.tb05369.x.

Abstract

C-terminal truncation of the middle surface antigen from hepatitis B virus (MHBs) gives rise to a novel transactivating protein, called MHBst. In this study we show that MHBst like the HBx protein of HBV, can cause nuclear appearance of NF-kappa B DNA binding activity and induce various kappa B-controlled reporter genes. While an inhibitor of protein kinase C could not block gene induction by MHBst, the antioxidants N-acetyl-L-cysteine (NAC) and pyrrolidine dithiocarbamate (PDTC) could potently suppress transactivation at mM and microM concentrations, respectively. Also, kappa B-dependent gene induction by the transactivator HBx was blocked. The effects were selective because PDTC did not interfere with MHBst and HBx-induced activation of the c-fos promoter/enhancer, nor with the basal activity of several other reporter genes lacking functional NF-kappa B binding motifs. Our data suggest that induction of a prooxidant state is crucial for the activation of NF-kappa B by MHBst and HBx and might be related to the hepatocarcinogenic potential of the viral proteins. MHBst had a subcellular localization unusual for a viral transactivator: it appeared to be an integral membrane protein of the endoplasmic reticulum.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / pharmacology*
  • Animals
  • Antioxidants / pharmacology*
  • Base Sequence
  • Blotting, Western
  • Cell Line
  • Cell Membrane / metabolism
  • Chloramphenicol O-Acetyltransferase / genetics
  • Chloramphenicol O-Acetyltransferase / metabolism
  • Fluorescent Antibody Technique
  • HeLa Cells
  • Hepatitis B Surface Antigens / genetics
  • Hepatitis B Surface Antigens / metabolism*
  • Hepatitis B virus / drug effects
  • Hepatitis B virus / genetics*
  • Humans
  • Molecular Sequence Data
  • NF-kappa B / metabolism*
  • Oligodeoxyribonucleotides
  • Protein Kinase C / antagonists & inhibitors
  • Pyrrolidines / pharmacology*
  • Recombinant Fusion Proteins / metabolism
  • Thiocarbamates / pharmacology*
  • Trans-Activators / genetics
  • Trans-Activators / metabolism*
  • Transfection

Substances

  • Antioxidants
  • Hepatitis B Surface Antigens
  • NF-kappa B
  • Oligodeoxyribonucleotides
  • Pyrrolidines
  • Recombinant Fusion Proteins
  • Thiocarbamates
  • Trans-Activators
  • pyrrolidine dithiocarbamic acid
  • Chloramphenicol O-Acetyltransferase
  • Protein Kinase C
  • Acetylcysteine